Human iPSC-derived cardiomyocytes: A translational model to predict drug-induced cardiac arrhythmias and long-term toxicity
Poster Sep 25, 2017
R Kettenhofen, G Luerman, R Bucerius, I Kopljar, DJ Gallacher, A De Bondt, E Vlaminckx, I Van Den Wyngaert, HR Lu, H Bohlen
Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes represent a promising model for in vitro prediction of cardiac arrhythmias. Currently, two commercially available hiPSC-derived cardioymocyte products - including Axiogenesis Cor.4U human cardiomyocytes - are validated in an international multi-coresite study inside the comprehensive in vitro Pro-arrhythmia (CiPA) consortium. This aims to change the paradigm of safety pharmacological assessment from the assessment of drug interaction with the hERG channel to a potentially clinically more relevant assay system using human iPSC-derived cardiomyocytes in MEA-, voltage- and calcium-sensitive dye recordings.
Besides CiPA, a variety of oncological drugs including tyrosine kinase and HDAC inhibitors have been reported to induce long-term cardiac toxicity in the clinic. Recent findings clearly show that Cor.4U cardioymocytes can be applied to a long-term impedance assay and the results from known drugs perfectly translate to the clinical observations.
The results shown here imply that iPSC-derived Cor.4U human cardioymocytes are a translational in vitro cell model for the prediction of clinically relevant drug-induced cardiac arrhythmias and long-term toxicity.
We utilized paired synthetic crRNAs coupled with our synthetic tracrRNA in cells transduced with lentiviral Cas9 to perform a functional knockout on hsa-miR-221. This three-part system (crRNA, tracrRNA and Cas9) has demonstrated efficient gene editing when used with only one guide RNA, but the goal was to use two crRNAs to remove the entire stem-loop.READ MORE
During early drug discovery, the study of metabolism plays an essential role in determining which drug candidates move forward into development and later stages. As an alternative to traditional Data Dependent Acquisition (DDA), the use of MSE/All Ions Fragmentation (AIF) has become common in metabolite identification workflows for the analysis of metabolic hot spots. Here we present a solution for analysis of MSE/AlF in metID studies.READ MORE
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019